Identification of a single nucleotide polymorphism in the TATA box of the CYP2A6 gene:: Impairment of its promoter activity

被引:123
作者
Pitarque, M
von Richter, O
Oke, B
Berkkan, H
Oscarson, M
Ingelman-Sundberg, M
机构
[1] Karolinska Inst, IMM, Div Mol Toxicol, Inst Environm Med, S-17177 Stockholm, Sweden
[2] Univ Istanbul, Fac Pharm, Dept Biochem, TR-34452 Istanbul, Turkey
关键词
coumarin; nicotine; lung cancer; gene transcription; genetic polymorphism; DASH;
D O I
10.1006/bbrc.2001.4990
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human cytochrome P450 2A6 (CYP2A6) constitutes the major nicotine oxidase, and large interindividual differences are seen in the levels of this enzyme, to a great extent caused by the distribution of several different polymorphic gene variants mainly located in the open reading frame (ORF). In the present study, we report a common polymorphism located in the 5 ' flanking region of CYP2A6 affecting its expression. DHPLC analysis and complete sequence of the open reading frame of the gene from a Turkish individual revealed a -48T > G substitution disrupting the TATA box. Using dynamic allele-specific hybridization (DASH), genotyping of this novel variant (named CYP2A6*9) was carried out in 116 Swedish, 132 Turkish, and 102 Chinese subjects, and the allele frequencies were found to be 5.2, 7.2, and 15.7%, respectively. The significance of the polymorphism was investigated by the construction of luciferase reporter plasmids containing 135 or 500 bp of the 5 ' -upstream region of the gene transfected into human hepatoma B16A2 cells. The constructs carrying the -48T > G mutation were only expressed at about 50% of the wild-type alleles. It is concluded that the CYP2A6*9 allele might be one of the most common CYP2A6 variants in Caucasians that alters the levels of enzyme expression. (C) 2001 Academic Press.
引用
收藏
页码:455 / 460
页数:6
相关论文
共 38 条
[1]   GENETIC SUSCEPTIBILITY TO LUNG-CANCER WITH SPECIAL EMPHASIS ON CYP1A1 AND GSTM1 - A STUDY ON HOST FACTORS IN RELATION TO AGE AT ONSET, GENDER AND HISTOLOGICAL CANCER TYPES [J].
ALEXANDRIE, AK ;
SUNDBERG, MI ;
SEIDEGARD, J ;
TORNLING, G ;
RANNUG, A .
CARCINOGENESIS, 1994, 15 (09) :1785-1790
[2]   A novel single nucleotide polymorphism altering stability and activity of CYP2A6 [J].
Ariyoshi, N ;
Sawamura, Y ;
Kamataki, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 281 (03) :810-814
[3]   Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter:: A balanced polymorphism for regulation of bilirubin metabolism? [J].
Beutler, E ;
Gelbart, T ;
Demina, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) :8170-8174
[4]  
Howell WM, 1999, NAT BIOTECHNOL, V17, P87, DOI 10.1038/5270
[5]  
JOHANSSON I, 1991, EUR J CLIN PHARMACOL, V40, P553
[6]  
Jones AC, 1999, CLIN CHEM, V45, P1133
[7]   Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes:: A study using adenovirus-mediated antisense targeting [J].
Jover, R ;
Bort, R ;
Gómez-Lechón, MJ ;
Castell, JV .
HEPATOLOGY, 2001, 33 (03) :668-675
[8]  
KITAGAWA K, 2001, J BIOL CHEM, V16, P16
[9]   STIMULATION OF RNA-POLYMERASE-II TRANSCRIPTION INITIATION BY RECRUITMENT OF TBP IN-VIVO [J].
KLAGES, N ;
STRUBIN, M .
NATURE, 1995, 374 (6525) :822-823
[10]   INCREASED RECRUITMENT OF TATA-BINDING PROTEIN TO THE PROMOTER BY TRANSCRIPTIONAL ACTIVATION DOMAINS IN-VIVO [J].
KLEIN, C ;
STRUHL, K .
SCIENCE, 1994, 266 (5183) :280-282